Discovery of Potent Nonpeptide Vasopressin Receptor Antagonists

Drug Discovery and Development

Volumn 1, Issue , 2006, Pages 313-337

  Maryanoff, Bruce E ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Nonpeptide vasopressin receptor antagonists; Novel chemotypes; Structure based approaches in drug discovery

Indexed keywords

EID: 33845494608     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471780103.ch11     Document Type: Chapter

References (133)

1. Maryanoff, B. E. J. Med. Chem. 2004, 47, 769-787.
2. Thayer, A. M. Chem. Eng. News 2003, 81, 33-37 (July 28).
3. Also see Service, R. F. Science 2004, 303, 1796-1799.
4. For information on TOPAMAX topiramate, refer to: www.topamax.com.
5. Also see Maryanoff, B. E.; Nortey, S. O.; Gardocki, J. F.; Shank, R. P.; Dodgson, S. P. J. Med. Chem. 1987, 3, 880-887.
6. Shank, R. P.; Gardocki, J. F.; Vaught, J. L.; Davis, C. B.; Schupsky, J. J.; Raffa, R. B.; Dodgson, S. J.; Nortey, S. O.; Maryanoff, B. E. Epilepsia 1994, 35, 450-460.
7. Maryanoff, B. E.; Costanzo, M. J.; Nortey, S. O.; Greco, M. N.; Shank, R. P.; Schupsky, J. J.; Ortegon, M. P.; Vaught, J. L. J. Med. Chem. 1998, 41, 1315-1343.
8. Shank, R. P.; Gardocki, J. F.; Streeter, A. J.; Maryanoff, B. E. Epilepsia 2000, 41(Suppl. 1), S3-S9.
9. Garnett, W. R. Epilepsia 2000, 41 (Suppl. 1), S61-S65.
10. Ben-Menachem, E. Rev. Contemp. Pharmacother. 1999, 10, 163-184.
11. Tomson, T. Curr. Sci. 2002, 82, 698-706.
12. Faught, E. Drugs Today 1999, 35, 49-57.
13. Michelucci, R.; Passarelli, D.; Riguzzi, P.; Volpi, L.; Tassinari, C. A. CNS Drug Rev. 1998, 4, 165-186.
14. Brandes, J. L.; Saper, J. R.; Diamond, M.; Couch, J. R.; Lewis, D. W.; Schmitt, J.; Neto, W.; Schwabe, S.; Jacobs, D. J. Am. Med. Assoc. 2004, 291, 965-973.
15. Costanzo, M. J.; Yabut, S. C.; Almond, H. R., Jr.; Andrade-Gordon, P.; Corcoran, T. W.; de Garavilla, L.; Kauffman, J. A.; Abraham, W. M.; Recacha, R.; Chattopadhyay, D.; Maryanoff, B. E. J. Med. Chem. 2003, 46, 3865-3876.
16. Greco, M. N.; Hawkins, M. J.; Powell, E. T.; Almond, H. R., Jr.; Corcoran, T. W.; de Garavilla, L.; Kauffman, J. A.; Recacha, R.; Chattopadhyay, D.; Andrade-Gordon, P.; Maryanoff, B. E. J. Am. Chem. Soc. 2002, 124, 3810-3811.
17. Greco, M. N.; Almond, H. R., Jr.; de Garavilla, L.; Hawkins, M. J.; Maryanoff, B. E.; Qian, Y.; Walker, D. G.; Cesco-Cancian, S.; Nilsen, C. N.; Patel, M. N.; Humora, M. J. PCT Intl. Patent Appl. WO 0335-654, 2003. A Novel, Potent Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase: molecular mechanisms and anti-inflammatory activity in vivo.
18. de Garavilla, Lawrence; Greco, Michael N.; Sukumar, Narayanasami; Chen, Zhi-Wei; Pineda, Agustin O.; Mathews, F. Scott; Di Cera, Enrico; Giardino, Edward C.; Wells, Grace I.; Haertlein, Barbara J.; Kauffman, Jack A.; Corcoran, Thomas W.; Derian, Claudia K.; Eckardt, Annette J.; Damiano, Bruce P.; Andrade-Gordon, Patricia; Maryanoff, Bruce E. Drug Discovery, School of Medicine, Johnson & Johnson Pharmaceutical Research and Development, Spring House, PA, USA. Journal of Biological Chemistry (2005), 280(18), 18001-18007.
19. Publisher: American Society for Biochemistry and Molecular Biology, CODEN: JBCHA3 ISSN: 0021-9258. Journal written in English. CAN 143: 19271 AN 2005: 379217 CAPLUS (Copyright © 2006 ACS on SciFinder (R)).
20. Hoekstra, W. J.; Maryanoff, B. E.; Andrade-Gordon, P.; Cohen, J. H.; Costanzo, M. J.; Damiano, B. P.; Haertlein, B.; Harris, B. D.; Kauffman, J. A.; Keane, P. M.; McComsey, D. F.; Villani, F. J., Jr.; Yabut, S. B. Bioorg. Med. Chem. Lett. 1996, 6, 2371-2376.
21. Hoekstra, W. J.; Poulter, B. L. Curr. Med. Chem. 1998, 5, 195-204.
22. Hoekstra, W. J.; Maryanoff, B. E.; Damiano, B. P.; Andrade-Gordon, P.; Cohen, J. H.; Costanzo, M. J.; Haertlein, B. J.; Hecker, L. R.; Hulshizer, B. L.; Kauffman, J. A.; Keane, P.; McComsey, D. F.; Mitchell, J. A.; Scott, L.; Shah, R. D.; Yabut, S. C. J. Med. Chem. 1999, 42, 5254-5265.
23. Damiano, B. P.; Mitchell, J. A.; Giardino, E.; Corcoran, T.; Haertlein, B. J.; de Garavilla, L.; Kauffman, J. A.; Hoekstra, W. J.; Maryanoff, B. E.; Andrade-Gordon, P. Thromb. Res., 2001, 104, 113-126.
24. Quinn, M. J.; Byzova, T. V.; Qin, J.; Topol, E. J.; Plow, E. F. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 945-952.
25. Salam, A. M.; Al Suwaidi, J. Expert Opin. Invest. Drugs 2002, 11, 1645-1658.
26. Quinn, M. J.; Plow, E. F.; Topol, E. J. Circulation 2002, 106, 379-385.
27. Chew, D. P.; Bhatt, D. L.; Topol, E. J. Am. J. Cardiovasc. Drugs 2001, 1, 421-428.
28. Chew, D. P.; Bhatt, D. L.; Sapp, S.; Topol, E. J. Circulation 2001, 103, 201-206.
29. Derian, C. K.; Maryanoff, B. E.; Zhang, H.-C.; Andrade-Gordon, P. Drug Dev. Res. 2003, 59, 355-366.
30. Maryanoff, B. E.; Zhang, H.-C.; Andrade-Gordon, P.; Derian, C. K. Curr. Med. Chem.-Cardiovasc. Hematol. Agents 2003, 1, 13-36.
31. Derian, C. K.; Maryanoff, B. E.; Zhang, H.-C.; Andrade-Gordon, P. Expert Opin. Invest. Drugs 2003, 12, 209-221.
32. Reeves, W. B.; Andreoli, T. E. In Williams Textbook of Endocrinology, 8th ed., Wilson, J. D.; Foster D. W. (Eds.), W.B. Saunders, Philadelphia, 1992, pp. 311-356.
33. Nielson, S.; Chou C. L.; Marples, D.; Christensen, E. I.; Kishore, B. K.; Knepper, M. A. Proc. Natl. Acad. Sci. USA 1995, 332, 1540-1545.
34. Anderson, R. J.; Chung, H.-M.; Kluge, R.; Schrier, R. W. Ann. Intern. Med. 1985, 102, 164-168.
35. Chung, H. M.; Kluge, R.; Schrier, R. W.; Anderson, R. J. Arch. Intern. Med. 1986, 146, 333-336.
36. Sane, T.; Rantakari, K.; Poranen, A.; Taehtelae, R.; Vaelimaeki, M.; Pelkonen, R. J. Clin. Endocrinol. Metab. 1994, 79, 1395-1398.
37. Kortas, C.; Bichet, D. G.; Rouleau, J. L.; Schreier, R. W. J. Cardiovasc. Pharmacol. 1986, 8 (suppl. 7), S107-S110.
38. Johnston, C. I.; Arnolda, L. F.; Tsunoda, K.; Phillips, P. A.; Hodsman, G. P. Can. J. Physiol. 1987, 65, 1706-1711.
39. Van Zwieten, P. A. Prog. Pharmacol. Clin. Pharmacol. 1990, 7, 49-66.
40. Thibonnier, M. Curr. Opin. Pharmacol. 2003, 3, 683-687.
41. Thibonnier, M.; Coles, P.; Thibonnier, A.; Shoham, M. Annu. Rev. Pharmacol. Toxicol. 2001, 41,175-202.
42. Mulinari, R. A.; Gavras, I.; Wang, Y. X.; Franko, R.; Gavras, H. Circulation 1990, 81, 308-311.
43. Naitoh, M.; Suzuki, H.; Murakamj, M.; Matsumoto, A.; Arakawa, K.; Ichihara, A.; Nakamoto, H.; Oka, K.; Yamamura, Y.; Saruta, T. Am. J. Physiol. 1994, 267, H2245-H2254.
44. Lee, C. R.; Watkins, M. L.; Patterson, J. H.; Gattis, W.; O'Connor, C. M.; Gheorghiade, M.; Adams, K. F., Jr. Am. Heart J. 2003, 146, 9-18.
45. Martin, P-Y.; Schrier, R. W. Kidney Int. 1997, 59, S43-S49.
46. Winnicki, C.; Warnawin, K.; Januszewicz, P.; Socha, J. Pol. J. Pediatr. Gastroenterol. Nutr. 1994,19, 425-430.
47. Tsuboi, Y.; Ishikawa, S.-E.; Fujisawa, G.; Okada, K.; Saito, T. Kidney Int. 1994, 46, 237-244.
48. Laszlo, F. A.; Csati, S.; Balaspiri, L. Acta Endocrinol. 1984, 106, 56-60.
49. Reeder, R. F.; Nattie, E. E.; North, W. G. J. Neurosurg. 1986, 64, 941-950.
50. Rosenberg, G. A.; Kyner, W. T.; Estrada, E.; Patlak, C. S. Ann. NY Acad. Sci. 1986, 481, 383-389.
51. Tang, A. H.; Ho, P. M. Life Sci. 1988, 43, 399-403.
52. Laszlo, F. A.; Varga, C.; Balaspiri, L. Ann. N.Y. Acad. Sci. 1993, 689, 627-629.
53. Thibonnier, M. Expert Opin. Invest. Drugs 1998, 7, 729-740.
54. Trybulski, E. J. Annu. Rep. Med. Chem. 2001, 36, 159-168.
55. Albright, J. D.; Chan, P. S. Curr. Pharm. Des. 1997, 3, 615-632.
56. Paranjape, S. B.; Thibonnier, M. Expert Opin. Invest. Drugs 2001, 10, 825-834.
57. Ruffolo, R. R.; Brooks, D. P.; Huffman, W. F.; Poste, G. Drug News Perspect. 1991, 4, 217-222.
58. Kinter, L. B.; Caltabiano, S.; Huffman, W. F. Biochem. Pharmacol. 1993, 45, 1731-1737.
59. Yamamura, Y.; Ogawa, H.; Chihara, T.; Kondo, K.; Onogawa, T.; Nakamura, S.; Mori, T.; Tominaga, M.; Yabuuchi, Y. Science 1991, 252, 572-574.
60. Ogawa, H.; Yamamura, Y.; Miyamoto, H.; Kondo, K.; Yamashita, H.; Nakaya, K.; Chihara, T.; Mori, T.; Tominaga, M.; Yabuuchi, Y J. Med. Chem. 1993, 36, 2011-2017.
61. Yamamura, Y.; Ogawa, H.;Yamashita, H.; Chihara, T.; Miyamoto, H.; Nakamura, S.; Onogawa, T.; Yamashita, H.; Hosokawa, T.; Mori, T.; Tominaga, M.; Yabuuchi, Y. Br. J. Pharmacol. 1992, 105, 787-791.
62. Ogawa, H.; Yamashita, H.; Kondo, K.; Yamamura, Y.; Miyamoto, H.; Kan, K.; Kitano, K.; Tanaka, M.; Nakaya, K.; Nakamura, S.; Mori, T.; Onogawa, T.; Tominaga, M.; Yabuuchi, Y. J. Med. Chem. 1996, 39, 3547-3555.
63. Manning, M.; Sawyer, W. H. J. Receptor Res. 1993, 13, 195-214.
64. Laszlo, F. A.; Laszlo, F., Jr.; De Weid, D. Pharmacol. Rev. 1991, 43, 73-108.
65. Manning, M.; Chan, W. Y.; Sawyer, W. H. Regul. Peptides 1993, 45, 279-283.
66. Fujisawa, G.; Ishikawa, S.; Tsuboi, Y.; Okada, K.; Saito, T. Kidney Int. 1993, 44, 19-23.
67. Ohnishi, A.; Orita, Y.; Takagi, N.; Fujita, T.; Toyoki, T.; Ihara, Y.; Yamamura, Y.; Inoue, T.; Tanaka, T. J. Pharmacol. Exp. Ther. 1995, 272, 546-551.
68. Kondo, K.; Ogawa, H.; Yamashita, H.; Miyamoto, H.; Tanaka, M.; Nakaya, K.; Kitano, K.; Yamamura, Y.; Nakamura, S.; Onogawa, T.; Mori, T.; Tominaga, M. Bioorg. Med. Chem. 1999, 7, 1743-1757.
69. Albright, J. D.; Reich, M. F.; Delos Santos, E. G.; Dusza, J. P., Sum, F.-W.; Venkatesan, A. M.; Coupet, J.; Chan, P. S.; Ru, X.; Mazandarani, H., Bailey, T. J. Med. Chem. 1998, 41, 2442-2444.
70. Aranapakam, V.; Albright, J. D.; Grosu, G. T.; Chan, P. S.; Coupet, J.; Saunders, T.; Ru, X.; Mazandarani, H. Bioorg. Med. Chem. Lett. 1999, 9, 1733-1736.
71. Aranapakam, V.; Albright, J. D.; Grosu, G. T.; Delos Santos, E. G.; Chan, P. S.; Coupet, J.; Ru, X.; Saunders, T.; Mazandarani, H. Bioorg. Med. Chem. Lett. 1999, 9, 1737-1740.
72. Albright, J. D.; Delos Santos, E. F.; Dusza, J. P.; Chan, P. S.; Coupet, J., Ru, X.; Mazandarani, H. Bioorg. Med. Chem. Lett. 2000, 10,695-698.
73. Ashwell, M. A.; Bagli, J. F.; Caggiano, T. J.; Chan, P. S.; Molinari, A. J.; Palka, C.; Park, C. H.; Rogers, J. F.; Sherman, M.; Trybulski, E. J.; Williams, D. K. Bioorg. Med. Chem. Lett. 2000, 10, 783-786.
74. Norman, P.; Leeson, P. A.; Rabasseda, X.; Castaner, J.; Castaner, R. M. Drugs Future 2000, 25, 1121-1130.
75. Matsuhisa, A.; Taniguchi, N.; Koshio, H.; Yatsu, T.; Tanaka, A. Chem. Pharm. Bull. 2000, 48, 21-31.
76. Shimada, Y.; Taniguchi, N.; Matsuhisa, A.; Sakamoto, K.; Yatsu, T.; Tanaka, A. Chem. Pharm. Bull. 2000, 48, 1644-1651.
77. Matsuhisa, A.; Kikuchi, K.; Sakamoto, K.; Yatsu, T.; Tanaka, A. Chem. Pharm. Bull. 1999, 47, 329-339.
78. Cho, H.; Murakami, K.; Nakanishi, H.; Fujisawa, A.; Isoshima, H.; Niwa, M.; Hayakawa, K.; Hase, Y.; Uchida, I.; Watanabe, H.; Wakitani, K.; Aisaka, K. J. Med. Chem. 2004, 47, 101-109.
79. Shimada, Y.; Taniguchi, N.; Matsuhisa, A.; Yatsu, T.; Tahara, A.; Tanaka, A. Chem. Pharm. Bull. 2003, 51, 1075-1080.
80. Sum, F.-W.; Dusza, J.; Delos Santos, E.; Grosu, G.; Reich, M.; Du, X.; Albright, J. D.; Chan, P.; Coupet, J.; Ru, X.; Mazandarani, H.; Saunders, T. Bioorg. Med. Chem. Lett. 2003, 13, 2195-2198.
81. Tsukada, J.; Tahara, A.; Tomura, Y.; Wada, K.; Kusayama, T.; Ishii, N.; Aoki, M.; Yatsu, T.; Uchida, W.; Taniguchi, N.; Tanaka, A. Eur. J. Pharmacol. 2002, 446, 129-138.
82. Kakefuda, A.; Suzuki, T.; Tobe, T.; Tsukada, J.; Tahara, A.; Sakamoto, S.; Tsukamoto, S. J. Med. Chem. 2002, 45, 2589-2598.
83. Ohtake, Y.; Naito, A.; Hasegawa, H.; Kawano, K.; Morizono, D.; Taniguchi, M.; Tanaka, Y.; Matsukawa, H.; Naito, K.; Oguma, T.; Ezure, Y.; Tsuriya, Y. Bioorg. Med. Chem. 1999, 7, 1247-1254.
84. Matthews, J. M.; Greco, M. N.; Hecker, L. R.; Hoekstra, W. J.; Andrade-Gordon, P.; de Garavilla, L.; Demarest, K. T.; Ericson, E.; Gunnet, J. W.; Hageman, W.; Look, R.; Moore, J. B.; Maryanoff, B. E. Bioorg. Med. Chem. Lett. 2003, 13, 753-756.
85. Dyatkin, A. B.; Hoekstra, W. J.; Hlasta, D. J.; Andrade-Gordon, P.; de Garavilla, L.; Demarest, K. T.; Gunnet, J. W.; Hageman, W.; Look, R.; Maryanoff, B. E. Bioorg. Med. Chem. Lett. 2002, 12, 3081-3084. [Corrigendum: Bioorg. Med. Chem. Lett. 2004, 14, 3363]
86. Matthews, J. M.; Hoekstra, W. J.; Dyatkin, A. B.; Hecker, L. R.; Hlasta, D. J.; Poulter, B. L.; Andrade-Gordon, P.; de Garavilla, L.; Demarest, K. T.; Ericson, E.; Gunnet, J. W.; Hageman, W.; Look, R.; Moore, J. B.; Reynolds, C. H.; Maryanoff, B. E. Bioorg. Med. Chem. Lett. 2004, 14, 2747-2752.
87. Matthews, J. M.; Hlasta, D. J.; Andrade-Gordon, P.; Demarest, K. T.; Ericson, E.; Gunnet, J. W.; Hageman, W.; Look, R.; Moore, J. B.; Maryanoff, B. E. Lett. Drug Design Discov. 2005, 2, 219-223.
88. Urbanski, M. J.; Chen, R. H.; Demarest, K. T.; Gunnet, J.; Look, R.; Ericson, E.; Murray, W. V.; Rybczynski, P. J.; Zhang, X. Bioorg. Med. Chem. Lett. 2003, 13, 4031-4034.
89. Xiang, M. A.; Chen, R. H.; Demarest, K. T.; Gunnet, J.; Look, R.; Hageman, W.; Murray, W. V.; Combs, D. W.; Patel, M. Bioorg. Med. Chem. Lett. 2004, 14, 2987-2989.
90. Xiang, M. A.; Chen, R. H.; Demarest, K. T.; Gunnet, J.; Look, R.; Hageman, W.; Murray, W. V.; Combs, D. W.; Rybczynski, P. J.; Patel, M. Bioorg. Med. Chem. Lett. 2004, 14, 3143-3146.
91. RWJ-351647 and RWJ-659834 are the subject of an issued U.S. patent (Mar. 30, 2004): Dyatkin, A. B.; Hoekstra, W. J.; Maryanoff, B. E.; Matthews, J. M. U.S. patent 6,713,475 (2004) [WO 0043398; EP 1147115].
92. Sorbera, L. A.; Castaner, J.; Bayes, M.; Silvestre, J. Drugs Future 2002, 27, 350-357.
93. Gheorghiade, M.; Niazi, I.; Ouyang, J.; Czerwiec, F.; Kambayashi, J.; Zampino, M.; Orlandi, C.Circulation 2003, 107, 2690-2696.
94. Martinez-Castelao, A. Curr. Opin. Invest. Drugs 2001, 2, 525-530.
95. Chan, P. S.; Coupet, J.; Park, H. C.; Lai, F.; Hartupee, D.; Cervoni, P.; Dusza, J. P.; Albright, J. D.; Ru, X.; Mazandarani, H.; Tanikella, T.; Shepherd, C.; Ochalski, L.; Bailey, T.; Lock, T. Yeung W.; Ning, X.; Taylor, J. R.; Spinelli, W. Adv. Exp. Med. Biol. 1998, 449, 439-443.
96. Martinez-Castelao, A. Curr. Opin. Invest. Drugs 2002, 3, 89-95.
97. Tahara, A.; Tomura, Y.; Wada, K.; Kusayama, T.; Tsukada, J.; Takanashi, M.; Yatsu, T.; Uchida, W.; Tanaka, A. J. Pharmacol. Exp. Ther. 1997, 282, 301-308.
98. Gerbes, A. L.; Guelberg, V.; Gines, P.; Decaux, G.; Gross, P.; Gandjini, H.; Djian, J. Gastroenterology 2003, 124, 933-939.
99. Martinez-Castelao, A. Curr. Opin. Invest. Drugs 2001, 2, 1423-1427.
100. Serradeil-Le Gal, C. Cardiovasc. Drug Rev. 2001, 19, 201-214.
101. Jimenez, W.; Serradeil-Le Gal, C.; Ros, J.; Cano, C.; Cejudo, P.; Morales-Ruiz, M.; Arroyo, V.; Pascal, M.; Rivera, F.; Maffrand, J.-P.; Rodes, J. J. Pharmacol. Exp. Ther. 2000, 295, 83-90.
102. Serradeil-Le Gal, C.; Wagnon, J.; Garcia, C.; Lacour, C.; Guiraudou, P.; Christophe, B.; Villanova, G.; Nisato, D.; Maffrand, J. P.; Le Fur, G.; Guillon, G.; Cantau, B.; Barberis, C.; Trueba, M.; Ala, Y.; Jard, S. J. Clin. Invest. 1993, 92, 224-231.
103. Serradeil-Le Gal, C.; Lacour, C.; Valette, G.; Garcia, G.; Foulon, L.; Galindo, G.; Bankir, L.; Pouzet, B.; Guillon, G.; Barberis, C.; Chicot, D.; Jard, S.; Vilain, P.; Garcia, C.; Marty, E.; Raufaste, D.; Brossard, G.; Nisato, D.; Maffrand, J. P.; Le Fur, G. J. Clin. Invest. 1996, 98, 2729-2738.
104. Griebel, G.; Simiand, J.; Serradeil-Le Gal, C.; Wagnon, J.; Pascal, M.; Scatton, B.; Maffrand, J.-P.; Soubrie, P. Proc. Natl. Acad. Sci. USA 2002, 99, 6370-6375.
105. Gard, P. Curr. Opin. Oncol. Endocrinol. Metabol. Invest. Drugs 2000, 2, 265-272.
106. Barberis, C.; Morin, D.; Durroux, T.; Mouillac, B.; Guillon, G.; Seyer, R.; Hibert, M.; Tribollet, E.; Manning, M. Drug News Perspect. 1999, 12, 279-292.
107. Barberis, C., Seibold, A., Ishido, M., Rosenthal, W., Birnbaumer, M. Regul. Peptides 1993, 45, 61-69.
108. Thibonnier, M.; Auzan, C.; Madhun, Z; Wilkins, P.; Berti-Mattera, L.; Clauser, E. J. Biol. Chem. 1994, 269, 3304-3310.
109. Hirasawa, A.; Shibata, K.; Kotosai, K.; Tsujimoto, G. Biochem. Biophys. Res. Commun. 1994, 203, 72-79.
110. Morel, A.; Lolait, S. J.; Brownstein, M. J. Regul. Peptides 1993, 45, 53-59.
111. Morel, A.; O'Carroll, A. M.; Brownstein, M. J.; Lolait, S. J. Nature 1992, 356, 523-526.
112. Lolait, S. J.; O'Carroll, A. M.; McBride, O. W.; Konig, M.; Morel, A.; Brownstein, M. J. Nature 1992, 357, 336-339.
113. Tahara, A.; Saito, M.; Sugimoto, T.; Tomura, Y.; Wada, K.; Kusayama, T.; Tsukada, J.; Ishii, N.; Yatsu, T.; Uchida, W.; Tanaka, A. Br. J. Pharmacol. 1998, 125, 1463-1470.
114. Oprea, T. I. J. Comput.-Aided Mol. Design 2000, 14, 251-264.
115. Walters, W. Patrick; A.; Murcko, M. A. Curr. Opin. Chem. Biol. 1999, 3, 384-387.
116. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
117. Hester, J. B., Jr. J. Org. Chem. 1964, 29, 1158-1160.
118. Hester, J. B., Jr. J. Org. Chem. 1967, 32, 4095-4098.
119. Nagasaka, T.; Ohki, S. Chem. Pharm. Bull. 1977, 25, 3023-3033.
120. Bergman, J.; Sand, P. Org. Synth. 1987, 65, 146-149.
121. Quick, J.; Saha, B. Tetrahedron Lett. 1994,35, 8553-8556.
122. There are some errors involving the interchange of compound numbers 4 and 5 in ref 30b, which are reported in the noted Corrigendum.
123. Abraham, H.; Stella, L. Tetrahedron 1992, 48, 9707-9718.
124. Bertilsson, S. K.; Ekegren, J. K.; Modin, S. A.; Andersson, P. G. Tetrahedron 2001, 57, 6399-6406.
125. Carabateas, P. M. U.S. patent 3,860,600 (1975); Chem. Abstr. 1975, 83, 58892.
126. Ohtake, Y.; Naito, A.; Naito, K.; Matsukawa, H.; Saito, Y.; Toyofuku, H. PCT Int. Appl. 1998, 1-156 (WO 9843976); Chem. Abstr. 1998, 129, 290149.
127. Dyatkin, A. B.; Freedman, T. B.; Cao, X.; Dukor, R. K.; Maryanoff, B. E.; Maryanoff, C. A.; Matthews, J. M.; Shah, R. D.; Nafie, L. A. Chirality 2002, 14, 215-219.
128. Matthews, J. M.; Dyatkin, A. B.; Evangelisto, M.; Gauthier, D. A.; Hecker, L. R.; Hoekstra, W. J.; Poulter, B. L.; Maryanoff, B. E. Tetrahedron: Asymmetry 2004, 15, 1259-1267.
129. SciFinder, Advanced chemistry development software, Solaris v4.67.
130. Hassner, A.; Amit, B.; Marks, V.; Gottlieb, H. E. J. Org. Chem. 2003, 68, 6853-6858.
131. Gieldon, A.; Kazmierkiewicz, R.; Slusarz, R.; Ciarkowski, J. J. Comput.-Aided Mol. Design 2001, 15, 1085-1104.
132. (R)-(+)-51 has the same spatial arrangement at the stereogenic center as does 40; however, the stereochemical descriptor for the absolute configuration of (+)-51 ["R"] differs from that of 40 ["S"] because of the Cahn-Ingold-Prelog priority rules: Cahn, R. S.; Ingold, C.; Prelog, V. Angew. Chem. Int. Ed. 1966, 5, 385-U5.
133. Inhibition of AVP activation of human V1b or oxytocin receptors in transfected HEK-293 cells.